Impact of the black triangle label on prescribing of new drugs in the United Kingdom: lessons for the United States at a time of deregulation

Nov-17

AUTHORS : Dr Daniel B. Horton, Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, 112 Paterson St, New Brunswick, NJ 08901, USA – Email: daniel.horton@rutgers.edu – Profile: https://pets.rutgers.edu/people/daniel-horton/

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 26(11):1307-1313

DOI : 10.1002/pds.4304

Impact of the black triangle label on prescribing of new drugs in the United Kingdom: lessons for the United States at a time of deregulation

More publications

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

The risk of immune-mediated inflammatory diseases following exposure to childhood maltreatment: a retrospective cohort study using UK primary care data